G220 150 (Lithium 150 mg)

Pill imprint G220 150 has been identified as Lithium carbonate 150 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; depression; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for G220 150 (Lithium 150 mg)

Lithium carbonate 150 mg G220 150
Lithium carbonate
Imprint:
G220
150
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0220
Inactive Ingredients:
FD&C Blue No. 1
FD&C Red No. 40
D&C Yellow No. 10
silicon dioxide
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
shellac
propylene glycol
potassium hydroxide
ferrosoferric oxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)